Biomedical Science

ResearcherAt Meharry Medical College our work in biomedical science is defining the underlying mechanisms of human disease, identifying new therapeutic targets responsible for disease, and laying the foundation for the development of novel therapies to counter disease. We work with DNA, tissues, microorganisms, viruses and complex proteins while taking into account race, socioeconomic status, gender and age in order to gain the pertinent knowledge that will enable us to serve the community. The Meharry Morphology Core is a microscopy facility that provides state of the art instrumentation, training, and data analysis to the Meharry Community to advance the understanding of biological systems by connecting basic and clinical findings with molecular scale mechanisms. Our faculty researchers provide new insights about the causes and treatments of various human diseases including cancer, diabetes, cardiomyopathies and infectious diseases like HIV/AIDS. Meharry is dedicated to educating and training M.D.s and Ph.D.s who become biomedical researchers, physician scientists and clinical investigators whose focus is to advance theoretical knowledge and create new technology for products and services that promote optimal health.


Research accomplishments have been funded by federal agencies such as Health Resources & Services Administration (HRSA), National Cancer Institute (NCI), National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of General Medical Sciences (NIGMS), Centers for Disease Control (CDC), Nuclear Regulatory Commission (NRC), National Science Foundation (NSF), Department of Education, National Center Minority Health/Health Disparities (NCMHD), National Human Genome Research Institute (NHGRI), Minority Institutions Program (RCMI) grant, State funding at Meharry includes Tennessee Department of Health (TDH). Foundation and Industry funding includes Fuji Oil Company, American Society for Cell Biology, Das, Gilead Sciences, Inc., Astellas Pharma US, Inc., Pfizer Inc., Merck Sharp & Dohme Corp., Genetech, Inc., Bayer AG, United Way of Metropolitan Nashville, Ford Foundation, Lakewood-Amedex, Inc., Patient Advocate Foundation, American Heart Association, and the Peter F. McManus Charitable Foundation among others.